$CSBR Income Statement | Understand Stock

$CSBR

$4.83 -$0.03 (0.62%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Apr 30, 2026	FY2025 12 months to Apr 30, 2025	FY2024 12 months to Apr 30, 2024	FY2023 12 months to Apr 30, 2023	FY2022 12 months to Apr 30, 2022
Oncology revenue
Costs and operating expenses:
Cost of oncology revenue
Research and development
Sales and marketing
General and administrative
Loss on disposal of equipment
Asset impairment
Total costs and operating expenses
Income (loss) from operations
Other income:
Other income, net
Income (loss) before income tax expense
Provision (benefit) for income tax
Net income (loss)
Net income (loss) per common share outstanding
basic (in dollars per share)
diluted (in dollars per share)
Weighted average common shares outstanding
basic (in shares)
diluted (in shares)

Comments